Most cited article - PubMed ID 33839618
Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma according to prior lines of treatment and refractory status: ICARIA-MM subgroup analysis
Leukemia research.
2021 May ;
104 () :
106576.
[epub] 20210329
American journal of hematology.
2023 Jan ;
98 (1) :
E15-E19.
[epub] 20220604
- MeSH
- Dexamethasone therapeutic use MeSH
- Antibodies, Monoclonal, Humanized therapeutic use MeSH
- Humans MeSH
- Neoplasm Recurrence, Local drug therapy MeSH
- Multiple Myeloma * drug therapy MeSH
- Antineoplastic Combined Chemotherapy Protocols therapeutic use MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- carfilzomib MeSH Browser
- Dexamethasone MeSH
- Antibodies, Monoclonal, Humanized MeSH
- isatuximab MeSH Browser
